Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

534
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

586
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
586
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

537
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
537
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of patent foramen ovale shunt severity by transesophageal echocardiogram and transcranial doppler in routine clinical practice.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2025
Same author

Atrial Arrhythmias After PFO Device Closure: Common, Clinically Important, and Preventable?

Circulation·2024
Same author

Some Practical Points About Patent Foramen Ovale Conditions that May Not Be Covered in the Rest of the Book.

Cardiology clinics·2024
Same author

Patent Foramen Ovale and Acute Mountain Sickness.

Cardiology clinics·2024
Same author

Patent Foramen Ovale and Coronary Artery Spasm: A New Patent Foramen Ovale-associated Condition that May Explain the Mechanism of Vasospastic Angina.

Cardiology clinics·2024
Same author

The Current State of Science Surrounding Patent Foramen Ovale.

Cardiology clinics·2024

Related Experiment Video

Updated: Feb 26, 2026

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

3.7K

Cardiac transplant vasculopathy.

Jonathan M Tobis1

  • 1Department of Medicine, Division of Cardiology, David Geffen School of Medicine at UCLA, BL-394 CHS UCLA, Los Angeles, California, 90095.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|July 15, 2017
PubMed
Summary
This summary is machine-generated.

Transplant vasculopathy, a progressive rejection form, poses challenges despite PCI with everolimus drug-eluting stents. These stents show effectiveness but do not prevent diffuse transplant vasculopathy progression.

More Related Videos

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
08:32

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Published on: December 4, 2010

12.8K
Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

6.8K

Related Experiment Videos

Last Updated: Feb 26, 2026

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

3.7K
Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
08:32

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Published on: December 4, 2010

12.8K
Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

6.8K

Area of Science:

  • Cardiology
  • Immunology
  • Transplantation

Background:

  • Transplant vasculopathy is a chronic rejection process impacting graft survival.
  • Interventional cardiologists manage this condition using percutaneous coronary intervention (PCI).

Discussion:

  • Everolimus drug-eluting stents (DES) are utilized to treat transplant vasculopathy.
  • While effective in reducing in-stent restenosis, these stents do not halt the diffuse progression of the disease.

Key Insights:

  • PCI with everolimus DES is a current strategy for managing transplant vasculopathy.
  • Transplant vasculopathy exhibits diffuse progression, indicating limitations of current stent-based therapies.

Outlook:

  • Further research is needed to address the diffuse nature of transplant vasculopathy.
  • Novel therapeutic strategies beyond current stenting approaches may be required for long-term graft maintenance.